SPECTRX, INC. / NORO-MOSELEY PARTNERS II, L.P.

Company

GUIDED THERAPEUTICS INC

Filed

February 13, 2001

Accession Number

0000950144-01-002367

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →